General Information
BounceWatch is an independent company data service, not affiliated with Salmedix. To contact Salmedix, visit salmedix.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Salmedix compare?
A PDF of Salmedix and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Salmedix soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Salmedix on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
About Salmedix
Business keywords: Oncology, Blood Cancers, Phase II Clinical Trials, Hematologic Malignancies, Drug Development, SDX-105, Healthcare Professionals, Germany, U.S., Canada, SDX-101, SDX-102, Clinical-Stage Product Candidates, David Kabakoff, San Diego
Funding Rounds & Investors (3)
View AllSalmedix Alternatives & Competitors
View All AlternativesChanging lives by changing the course of blood cancer.
Pioneering pharmaceuticals in the fight against blood cancers since 2000
Adastra is committed to transforming cancer care.
FAQ About Salmedix
Source: BounceWatch company record for Salmedix, https://bouncewatch.com/company/salmedix, updated 27 December 2024. When citing, please name BounceWatch and link this page.